Roxithromycin Supplier-Buyer Network — Trade Flow Analysis

Name: Roxithromycin Supplier-Buyer Trade Network Dataset — 78+ Indian Exporters, 15+ Importers, 30+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Roxithromycin supplier network, Roxithromycin buyers, pharmaceutical export India, Roxithromycin trade data

TransData Nexus

Roxithromycin

India Pharmaceutical Trade Intelligence

$4.2M78 Suppliers30 CountriesHS 30049099

ExportsIndia → VIETNAM33.9%India → CAMBODIA18.3%

ImportsGERMANY → India$752

#1 Supplier: BRAWN LABORATORIES

Who Supplies Roxithromycin? Top Manufacturers & Buyers 2026 — BRAWN LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1BRAWN LABORATORIES LIMITED

BRAWN LABORATORIES LIMITED is the first-largest Roxithromycin exporter from India, with a market share of 26.3% and a total export value of $1.1M across 14 shipments. Their average shipment value of $78.3K is above the market average of $9.8K, suggesting premium or bulk contract pricing.

BRAWN LABORATORIES LIMITED serves 5 named buyers in our database. MILITARY COMMERICAL JOINT STOCK BANK is the dominant customer, accounting for 53.9% of this supplier's tracked business. Top customers include:

• MILITARY COMMERICAL JOINT STOCK BANK — $590.8K across 8 shipments (53.9% of this supplier's total exports)

• MILITARY COMMERICAL JOINT STOCK BANK — $295.6K across 4 shipments (27.0% of this supplier's total exports)

• MILITARY COMMERCIAL — $160.5K across 2 shipments (14.6% of this supplier's total exports)

• GRACE WIN COMPANY LI — $32.8K across 0 shipments (3.0% of this supplier's total exports)

• ADVANCED BANK OF ASI — $16.4K across 0 shipments (1.5% of this supplier's total exports)

Key Insight: BRAWN LABORATORIES LIMITED's per-shipment value of $78.3K is 701% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.

2STRIDES PHARMA SCIENCE LIMITED

STRIDES PHARMA SCIENCE LIMITED is the second-largest Roxithromycin exporter from India, with a market share of 10.5% and a total export value of $438.9K across 54 shipments. Their average shipment value of $8.1K is below the market average of $9.8K, reflecting a high-volume, competitive pricing strategy.

STRIDES PHARMA SCIENCE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ARROW PHARMACEUTICALS PTY LTD — $150.2K across 18 shipments (34.2% of this supplier's total exports)

• APOTEX PTY LTD., — $96.9K across 12 shipments (22.1% of this supplier's total exports)

• APOTEX PTY LIMITED — $77.0K across 9 shipments (17.5% of this supplier's total exports)

• ARROW PHARMACEUTICALS PTY LTD — $62.0K across 8 shipments (14.1% of this supplier's total exports)

• APOTEX PTY LTD., — $52.8K across 6 shipments (12.0% of this supplier's total exports)

Key Insight: STRIDES PHARMA SCIENCE LIMITED operates with high shipment frequency (54 shipments) at a per-shipment value of $8.1K, indicating a broad distribution network with many smaller, regular orders.

3MARKSANS PHARMA LIMITED

MARKSANS PHARMA LIMITED is the third-largest Roxithromycin exporter from India, with a market share of 9.8% and a total export value of $408.9K across 15 shipments. Their average shipment value of $27.3K is above the market average of $9.8K, suggesting premium or bulk contract pricing.

MARKSANS PHARMA LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TEVA PHARMA NEW ZEALAND LIMITED — $170.2K across 6 shipments (41.6% of this supplier's total exports)

• TEVA PHARMA NEW ZEALAND LIMITED — $128.3K across 5 shipments (31.4% of this supplier's total exports)

• ISKP PHARMA CO., LTD — $82.6K across 3 shipments (20.2% of this supplier's total exports)

• ISKP PHARMA CO., LTD — $27.8K across 1 shipments (6.8% of this supplier's total exports)

Key Insight: MARKSANS PHARMA LIMITED's per-shipment value of $27.3K is 179% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.

4TORRENT PHARMACEUTICALS LTD

TORRENT PHARMACEUTICALS LTD is the fourth-largest Roxithromycin exporter from India, with a market share of 4.6% and a total export value of $191.6K across 14 shipments. Their average shipment value of $13.7K is above the market average of $9.8K, suggesting premium or bulk contract pricing.

TORRENT PHARMACEUTICALS LTD serves 3 named buyers in our database. HEUMANN PHARMA GMBH CO. GENERICA KG is the dominant customer, accounting for 83.4% of this supplier's tracked business. Top customers include:

• HEUMANN PHARMA GMBH CO. GENERICA KG — $159.7K across 12 shipments (83.4% of this supplier's total exports)

• HEUMANN PHARMA GMBH CO. GENERICA KG — $26.1K across 2 shipments (13.6% of this supplier's total exports)

• HEUMANN PHARMA GMBH CO. GENERICA KG — $5.7K across 0 shipments (3.0% of this supplier's total exports)

Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $13.7K is 40% above the market average of $9.8K, consistent with large-order contracts or value-added formulations.

5MICRO LABS LIMITED

MICRO LABS LIMITED is the fifth-largest Roxithromycin exporter from India, with a market share of 1.2% and a total export value of $52.1K across 7 shipments. Their average shipment value of $7.4K is below the market average of $9.8K, reflecting a high-volume, competitive pricing strategy.

MICRO LABS LIMITED serves 2 named buyers in our database. PPS INTERNATIONAL CO is the dominant customer, accounting for 52.0% of this supplier's tracked business. Top customers include:

• PPS INTERNATIONAL CO — $27.1K across 4 shipments (52.0% of this supplier's total exports)

• NUTRI-PHARMA USA COMPANY LIMITED — $25.0K across 3 shipments (48.0% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED operates with high shipment frequency (7 shipments) at a per-shipment value of $7.4K, indicating a broad distribution network with many smaller, regular orders.

6GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED

GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED is the fifth-largest Roxithromycin exporter from India, with a market share of 0.1% and a total export value of $5.9K across 12 shipments. Their average shipment value of $495 is below the market average of $9.8K, reflecting a high-volume, competitive pricing strategy.

GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED serves 3 named buyers in our database. OPHAM -ROUTE DIGUE A is the dominant customer, accounting for 92.7% of this supplier's tracked business. Top customers include:

• OPHAM -ROUTE DIGUE A — $5.5K across 11 shipments (92.7% of this supplier's total exports)

• GOLDEN SPIRIT TRADIN — $319 across 1 shipments (5.4% of this supplier's total exports)

• NOUVELLE PSP COTE D — $111 across 0 shipments (1.9% of this supplier's total exports)

Key Insight: GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED operates with high shipment frequency (12 shipments) at a per-shipment value of $495, indicating a broad distribution network with many smaller, regular orders.

1Vietnam

Vietnam ranks as the first-largest destination for Roxithromycin imports from India, with a total trade value of $1.4M across 10 shipments — representing a 33.9% share of all Roxithromycin exports. The average shipment value of $141.3K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Roxithromycin importers in Vietnam: MILITARY COMMERICAL JOINT STOCK BANK is the largest buyer, accounting for 41.8% ($590.8K) of this market's total imports.

• MILITARY COMMERICAL JOINT STOCK BANK — $590.8K (41.8% of Vietnam's total)

• CAMEL INTERNATIONAL IM-EXPORT — $93.2K (6.6% of Vietnam's total)

• NUTRI-PHARMA USA COMPANY LIMITED — $83.1K (5.9% of Vietnam's total)

Key Insight: Vietnam's per-shipment average of $141.3K (1346% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Vietnam is a key market for Roxithromycin imports from India.

Primary Market

Secondary Market

2Cambodia

Cambodia ranks as the second-largest destination for Roxithromycin imports from India, with a total trade value of $763.2K across 4 shipments — representing a 18.3% share of all Roxithromycin exports. The average shipment value of $190.8K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Roxithromycin importers in Cambodia: ISKP PHARMA CO., LTD is the largest buyer, accounting for 21.6% ($164.8K) of this market's total imports.

• ISKP PHARMA CO., LTD — $164.8K (21.6% of Cambodia's total)

Key Insight: Cambodia's per-shipment average of $190.8K (1852% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Cambodia is a key market for Roxithromycin imports from India.

Primary Market

Secondary Market

3Australia

Australia ranks as the third-largest destination for Roxithromycin imports from India, with a total trade value of $758.8K across 45 shipments — representing a 18.2% share of all Roxithromycin exports. The average shipment value of $16.9K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 6 tracked buyers.

Named Roxithromycin importers in Australia: APOTEX PTY LTD., is the largest buyer, accounting for 24.1% ($182.5K) of this market's total imports.

• APOTEX PTY LTD., — $182.5K (24.1% of Australia's total)

• ARROW PHARMACEUTICALS PTY LTD, — $150.2K (19.8% of Australia's total)

• ARROW PHARMACEUTICALS PTY LTD., — $112.2K (14.8% of Australia's total)

Key Insight: Australia's per-shipment average of $16.9K (73% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Australia is a key market for Roxithromycin imports from India.

Primary Market

Secondary Market

4New Zealand

New Zealand ranks as the fourth-largest destination for Roxithromycin imports from India, with a total trade value of $405.4K across 10 shipments — representing a 9.7% share of all Roxithromycin exports. The average shipment value of $40.5K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Roxithromycin importers in New Zealand: TEVA PHARMA (NEW ZEALAND) LIMITED is the largest buyer, accounting for 58.0% ($235.2K) of this market's total imports.

• TEVA PHARMA (NEW ZEALAND) LIMITED — $235.2K (58.0% of New Zealand's total)

• TEVA PHARMA NEW ZEALAND LIMITED — $170.2K (42.0% of New Zealand's total)

Key Insight: New Zealand's per-shipment average of $40.5K (315% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

New Zealand is a key market for Roxithromycin imports from India.

Primary Market

Secondary Market

5Myanmar

Myanmar ranks as the fifth-largest destination for Roxithromycin imports from India, with a total trade value of $233.2K across 0 shipments — representing a 5.6% share of all Roxithromycin exports. The average shipment value of $233.2K is above the global average of $9.8K, indicating high-value procurement contracts or branded formulations.

Key Insight: Myanmar's per-shipment average of $233.2K (2286% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Myanmar is a key market for Roxithromycin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Roxithromycin.
2.Flow Mapping: 78 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 427 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 30 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

427 Verified Shipments

78 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Roxithromycin

Roxithromycin

Who Supplies Roxithromycin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Roxithromycin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Roxithromycin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1BRAWN LABORATORIES LIMITED

2STRIDES PHARMA SCIENCE LIMITED

3MARKSANS PHARMA LIMITED

4TORRENT PHARMACEUTICALS LTD

5MICRO LABS LIMITED

6GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Roxithromycin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Roxithromycin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Vietnam

2Cambodia

3Australia

4New Zealand

5Myanmar

People Also Ask — Roxithromycin Supplier & Trade Network

Roxithromycin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology